1. Kim YS, Kim SM, Peck KR, Shin HS, Cho SU, Bae HJ, et al. Clinical study on invasive aspergillosis. Korean J Intern Med. 1990. 38:526–538.
2. Yoo JS, Choi SK, Yoon HJ, Cho KS, Park JC, Lee YH, et al. A case of invasive aspergillosis associated with acuteleukemia. Korean J Intern Med. 1987. 33:814–821.
3. Chung JW, Yang DH, Kim SH, Lee SR, Kim YK, Lee JJ, et al. A case of successful treatment of central nervous system (CNS) aspergillosis after hematopoietic stem cell transplantation with voriconazole. Korean J Med. 2006. 71:Suppl 3. 1095–1100.
4. Kang JM, Woo JH, Ryu JS. Invasive aspergillosis and the clinical management. Korean J Med Mycol. 2002. 7:14–21.
5. Ng TT, Robson GD, Denning DW. Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis. Microbiology. 1994. 140(Pt 9):2475–2479.
6. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002. 347:408–415.
7. Böhme A, Ruhnke M, Buchheidt D, Karthaus M, Einsele H, Guth S, et al. Treatment of fungal infections in hematology and oncology: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol. 2003. 82:Suppl 2. S133–S140.
8. Arroll B, Goodyear-Smith F. Corticosteroid injections for osteoarthritis of the knee: meta-analysis. BMJ. 2004. 328:869.
9. Lacy CF, Armstrong LL, Goldman MP, Lance LL. Druginformation. 2009. Hudson, OH: American Pharmacists Association;1579–1582.
10. Kumar S, Singh RJ, Reed AM, Lteif AN. Cushing's syndrome after intra-articular and intradermal administration of triamcinolone acetonide in three pediatric patients. Pediatrics. 2004. 113:1820–1824.